(Q47882689)

6 February 2018

title

Antimigraine drugs: new frontiers (English)

1 reference

6 February 2018

author name string

A Rapoport

series ordinal

1

1 reference

6 February 2018

publication date

1 May 2009

1 reference

6 February 2018

published in

Neurological Sciences

1 reference

6 February 2018

volume

30 Suppl 1

1 reference

6 February 2018

page(s)

S49-54

1 reference

6 February 2018

CGRP-receptor antagonism in migraine treatment

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10072-009-0069-Z

Botulinum toxin type A and divalproex sodium for prophylactic treatment of episodic or chronic migraine

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10072-009-0069-Z

Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine

21 January 2018

1 reference

12 December 2020

Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine

1 reference

12 December 2020

Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial

1 reference

12 December 2020

New and future migraine therapy

1 reference

12 December 2020

Pharmacokinetics and safety of ketorolac following single intranasal and intramuscular administration in healthy volunteers

1 reference

12 December 2020

Safety and pharmacokinetics of dihydroergotamine mesylate administered via a Novel (Tempo) inhaler

1 reference

12 December 2020

Calcitonin gene-related peptide does not excite or sensitize meningeal nociceptors: implications for the pathophysiology of migraine

1 reference

12 December 2020

Aerosol delivery of ergotamine tartrate via a breath-synchronized plume-control inhaler in humans

1 reference

12 December 2020

Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study

1 reference

12 December 2020

A double-blind study of SB-220453 (Tonerbasat) in the glyceryltrinitrate (GTN) model of migraine.

1 reference

12 December 2020

The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats.

1 reference

12 December 2020

10.1007/S10072-009-0069-Z

Identifiers

DOI

1 reference

6 February 2018

1 reference

6 February 2018